Jurgen Weymann

Follow

Person

Bad Durkheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antineoplastic peptides
- Patent number 8,440,626
- Issue date May 14, 2013
- Abbott GmbH & Co. KG
- Wilhelm Amberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metabolites and derivatives of ambrisentan
- Patent number 8,217,155
- Issue date Jul 10, 2012
- Gilead Colorado, Inc.
- Lawrence S. Melvin, Jr.
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antineoplastic peptides
- Patent number 7,807,779
- Issue date Oct 5, 2010
- Abbott GmbH & Co. KG
- Wilhelm Amberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Defined enzyme mixtures for obtaining cells and treating wounds
- Patent number 6,146,626
- Issue date Nov 14, 2000
- Knoll Aktiengesellschaft
- Claus Otto Markert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTINEOPLASTIC PEPTIDES
- Publication number 20110098235
- Publication date Apr 28, 2011
- ABBOTT GmbH & Co. KG
- Wilhelm Amberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METABOLITES AND DERIVATIVES OF AMBRISENTAN
- Publication number 20100204163
- Publication date Aug 12, 2010
- Gilead Colorado, Inc.
- Lawrence S. Melvin, JR.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antineoplastic peptides
- Publication number 20080234205
- Publication date Sep 25, 2008
- ABBOTT GmbH & Co. KG
- Wilhelm Amberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antineoplastic peptides
- Publication number 20060009392
- Publication date Jan 12, 2006
- Abbott GMBH & Co., KG.
- Wilhelm Amberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antineoplastic peptides
- Publication number 20010009901
- Publication date Jul 26, 2001
- BASF Aktiengesellschaft Germany
- Wilhelm Amberg
- C07 - ORGANIC CHEMISTRY